Publications

Warner C. Greene, MD, PhDSantiago ML, Smith DS, Barrett BS, Montano M, Benitez RL, Pelanda R, Hasenkrug KJ, Greene WC. Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor. J Virol. 2011 Jan; 85(1):189-99. View in: PubMed
Warner Greene, MD, PhDHIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells. View in: PubMed
Warner C. Greene, MD, PhDLassen KG, Wissing S, Lobritz MA, Santiago M, Greene WC. Identification of two APOBEC3F splice variants displaying HIV-1 antiviral activity and contrasting sensitivity to Vif. J Biol Chem. 2010 Sep 17; 285(38):29326-35. View in: PubMed
Warner Greene, MD, PhDPersistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor. View in: PubMed
Warner C. Greene, MD, PhDKim KA, Yolamanova M, Zirafi O, Roan NR, Staendker L, Forssmann WG, Burgener A, Dejucq-Rainsford N, Hahn BH, Shaw GM, Greene WC, Kirchhoff F, Münch J. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Retrovirology. 2010; 7:55. View in: PubMed
Warner Greene, MD, PhDIdentification of two APOBEC3F splice variants displaying HIV-1 antiviral activity and contrasting sensitivity to Vif. View in: PubMed
Warner C. Greene, MD, PhDSantiago ML, Benitez RL, Montano M, Hasenkrug KJ, Greene WC. Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. J Immunol. 2010 Jul 15; 185(2):1114-23. View in: PubMed
Warner Greene, MD, PhDSemen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. View in: PubMed
Warner Greene, MD, PhDInnate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. View in: PubMed
Warner C. Greene, MD, PhDWissing S, Galloway NL, Greene WC. HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors. Mol Aspects Med. 2010 Oct; 31(5):383-97. View in: PubMed